Inactive Instrument

Insiders Trillium Therapeutics

Equities

TRIL

CA89620X5064

Insiders

Unlock all the news: Be the first to know and act before the market!

TCR2 Therapeutics Appoints Chief Business and Strategy Officer	12/01/22	MT
Trillium Therapeutics Inc. Announces Executive Changes	17/11/21	CI
Trillium Therapeutics Inc. Announces Resignation of Jan Skvarka as Chief Executive Officer	17/11/21	CI
Trillium Therapeutics Inc. Appoints Catherine Mackey as a Member of the Board	30/06/21	CI
Trillium Therapeutics Inc. Board Changes	28/04/21	CI
Trillium Therapeutics Inc. Appoints Paolo Pucci to Its Board of Directors	12/11/20	CI
Trillium Therapeutics Inc. Announces Executive Changes	02/11/20	CI
Trillium Therapeutics : Forms Advisory Board With Heavyweight Cancer Researchers; Also Appoints Chief Medical Officer	02/11/20	MT
Trillium Therapeutics Inc. Announces the Formation of Scientific Advisory Board	02/11/20	CI
Trillium Therapeutics Inc. Appoints Michael Kamarck to Its Board of Directors, Effective Immediately	18/09/20	CI
Jeff Settleman Agrees to Join Trillium Therapeutics Inc.'s Scientific Advisory Board	09/09/20	CI
Trillium Therapeutics Inc. Announces the Retirement of Dr. Calvin Stiller and Dr. Michael Moore from the Board	06/07/20	CI
Trillium Therapeutics Inc. Announces Changes to its Board of Directors	07/02/20	CI
Trillium Therapeutics Inc. Names Jan Skvarka as President and Chief Executive Officer	25/09/19	CI
Trillium Therapeutics Inc. Announces Management and Board Changes; Provides Corporate Update; Opens Office in Cambridge, Massachusetts	30/04/19	CI
Trillium Therapeutics Appoints Yaping Shou, MD, PhD as Chief Medical Officer	07/06/18	CI
Trillium Appoints Dr. Henry Friesen as Director Emeritus and Retirement from the Board of Directors	05/06/18	CI
Trillium Therapeutics Inc Announces Executive Appointments	17/01/18	CI
Trillium Therapeutics Inc. Appoints Helen Tayton-Martin to its Board of Directors	11/10/17	CI
Trillium Therapeutics Inc. Appoints Eric L. Sievers as Chief Medical Officer	27/03/15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Trillium Therapeutics

Equities

TRIL

CA89620X5064

Insiders

Filters